Advertisement

Topics

NovaBay Pharmaceuticals Reports Third Quarter 2017 Financial Results

16:05 EST 14 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Enters into a $10.3 million financing on favorable terms Pharmacy channel sales increase 67% over prior year, represent 90% of total Avenova sales Revises 2017 financial guidance Conference call...

Other Sources for this Article

NovaBay Contacts
For NovaBay Avenova purchasing information:
Please call us toll free: 1-800-890-0329 or email sales@avenova.com
www.Avenova.com
or
From the Company
NovaBay Pharmaceuticals, Inc.
Jack McGovern
Chief Financial Officer
510-899-8800
jmcgovern@novabay.com
or
Investor Contact
LHA Investor Relations
Jody Cain
310-691-7100
Jcain@lhai.com

NEXT ARTICLE

More From BioPortfolio on "NovaBay Pharmaceuticals Reports Third Quarter 2017 Financial Results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...